InsiderClue
Stocks · Health care · Pharmaceutical Preparations

GENELUX Corp

GNLX Clue Score27
United States Fiscal year ends December CIK 0001231457 Results filed 25 Mar 2025
Add to watchlist

What the insiders did Net selling

Individual transactions

152
Insider
Date
Role
Action
Shares
Price
Amount
Yong Yu
3 Nov 2026
Chief Scientific Officer
Sell
668
$2.01
$1.34K
Thomas Zindrick
3 Nov 2026
President and CEO
Sell
3,089
$2.05
$6.32K
Joseph Cappello
3 Nov 2026
Chief Technical Officer
Sell
668
$2.04
$1.36K
Yong Yu
31 Aug 2026
Chief Scientific Officer
Sell
9,683
$2.75
$26.66K
Thomas Zindrick
31 Aug 2026
President and CEO
Sell
34,463
$2.67
$91.90K
Joseph Cappello
31 Aug 2026
Chief Technical Officer
Sell
10,257
$2.74
$28.11K
Thomas Zindrick
4 Aug 2026
President and CEO
Sell
3,023
$2.95
$8.91K
Joseph Cappello
4 Aug 2026
Chief Technical Officer
Sell
653
$2.95
$1.92K
Yong Yu
4 Aug 2026
Chief Scientific Officer
Sell
653
$2.94
$1.92K
John W Smither
1 Jul 2026
Director
Sell
12,000
$2.91
$34.90K
Ralph Smalling
3 Jun 2026
Head of Regulatory
Sell
192
$2.93
$562.56
John Thomas
1 Jun 2026
Director
Sold on a plan
10,000
$2.98
$29.80K
Ralph Smalling
11 May 2026
Head of Regulatory
Sell
270
$2.98
$804.49
Thomas Zindrick
11 May 2026
President and CEO
Sell
2,798
$2.94
$8.23K
Joseph Cappello
11 May 2026
Chief Technical Officer
Sell
605
$2.97
$1.80K
Yong Yu
11 May 2026
Chief Scientific Officer
Sell
605
$2.97
$1.80K
Ralph Smalling
25 Mar 2026
Head of Regulatory
Sell
240
$2.51
$602.40
Thomas Zindrick
24 Mar 2026
President and CEO
Sell
3,582
$2.42
$8.67K
Yong Yu
24 Mar 2026
SVP, Clinical Development
Sell
906
$2.42
$2.19K
Joseph Cappello
24 Mar 2026
Chief Technical Officer
Sell
906
$2.42
$2.19K
Ralph Smalling
24 Mar 2026
Head of Regulatory
Sell
345
$2.42
$834.90
John Thomas
2 Mar 2026
Director
Sold on a plan
10,000
$2.90
$28.96K
Ralph Smalling
5 Dec 2025
Head of Regulatory
Sell
165
$4.69
$773.85
John Thomas
1 Dec 2025
Director
Sold on a plan
10,000
$5.00
$50.01K
Ralph Smalling
17 Nov 2025
Head of Regulatory
Sell
343
$5.37
$1.84K
Joseph Cappello
17 Nov 2025
Chief Technical Officer
Sell
973
$5.37
$5.22K
Thomas Zindrick
17 Nov 2025
President and CEO
Sell
4,509
$5.37
$24.21K
Yong Yu
17 Nov 2025
SVP, Clinical Development
Sell
973
$5.37
$5.22K
Ralph Smalling
3 Sep 2025
Head of Regulatory
Sell
580
$3.36
$1.95K
Ralph Smalling
21 Aug 2025
Head of Regulatory
Sell
1,244
$3.36
$4.18K
Joseph Cappello
21 Aug 2025
Chief Technical Officer
Sell
1,463
$3.36
$4.91K
Joseph Cappello
21 Aug 2025
Chief Technical Officer
Sell
1,270
$3.33
$4.22K
Thomas Zindrick
21 Aug 2025
President and CEO
Sell
12,673
$3.33
$42.16K
Yong Yu
21 Aug 2025
SVP, Clinical Development
Sell
3,219
$3.36
$10.81K
Ralph Smalling
12 May 2025
Head of Regulatory
Sell
1,259
$2.92
$3.68K
Joseph Cappello
12 May 2025
VP, Pharmaceutical Development
Sell
4,737
$2.92
$13.83K
Yong Yu
12 May 2025
VP, Clinical Trial Operations
Sell
5,579
$2.92
$16.29K
Thomas Zindrick
12 May 2025
President and CEO
Sell
10,764
$2.92
$31.43K
Sean Ryder
12 May 2025
General Counsel
Sell
4,475
$2.92
$13.07K
James L Tyree
30 Dec 2024
Director
Sell
3,460
$2.46
$8.51K
Joseph Cappello
16 Dec 2024
VP, Pharmaceutical Development
Sell
6,300
$2.34
$14.74K
Ralph Smalling
16 Dec 2024
Head of Regulatory
Sell
2,510
$2.34
$5.87K
Lourie S. Zak
16 Dec 2024
Chief Financial Officer
Sell
2,103
$2.34
$4.92K
Thomas Zindrick
16 Dec 2024
President and CEO
Sell
14,315
$2.34
$33.50K
Aladar Szalay
13 Sep 2024
10% owner
Sell indirect
33,080
$2.57
$84.95K
Aladar Szalay
12 Sep 2024
10% owner
Sell indirect
31,777
$2.73
$86.73K
Aladar Szalay
11 Sep 2024
10% owner
Sell indirect
31,376
$2.62
$82.23K
James L Tyree
11 Sep 2024
Director
Sold on a plan
1,730
$2.60
$4.50K
Aladar Szalay
10 Sep 2024
10% owner
Sell indirect
20,384
$2.51
$51.18K
Aladar Szalay
9 Sep 2024
10% owner
Sell indirect
23,383
$2.70
$63.20K
Aladar Szalay
3 Sep 2024
10% owner
Sell indirect
42,818
$2.09
$89.61K
Aladar Szalay
30 Aug 2024
10% owner
Sell indirect
142,589
$2.17
$309.85K
Aladar Szalay
29 Aug 2024
10% owner
Sell indirect
107,045
$1.98
$211.96K
Aladar Szalay
28 Aug 2024
10% owner
Sell indirect
15,918
$2.05
$32.60K
Aladar Szalay
27 Aug 2024
10% owner
Sell indirect
51,630
$2.11
$108.86K
Aladar Szalay
23 Aug 2024
10% owner
Sell indirect
40,000
$2.29
$91.42K
Caroline Jewett
24 Jun 2024
Head of Quality
Sell
4,961
$2.12
$10.52K
Sean Ryder
24 Jun 2024
General Counsel
Sell
5,496
$2.12
$11.65K
Yong Yu
24 Jun 2024
VP, Clinical Trial Operations
Sell
6,849
$2.12
$14.52K
Lourie S. Zak
29 May 2024
Chief Financial Officer
Buy
31,250
—
no price
Sean Ryder
29 May 2024
General Counsel
Buy
10,000
—
no price
Ralph Smalling
29 May 2024
Head of Regulatory
Buy
1,250
—
no price
Thomas Zindrick
29 May 2024
President and CEO
Buy indirect
200,000
—
no price
Yong Yu
29 May 2024
VP, Clinical Trial Operations
Buy
2,500
—
no price
Mary Mirabelli
29 May 2024
Director
Buy
8,000
—
no price
John Thomas
29 May 2024
Director
Buy
2,500
—
no price
John W Smither
29 May 2024
Director
Buy
6,250
—
no price
James L Tyree
29 May 2024
Director
Buy
6,250
—
no price
Aladar Szalay
15 May 2024
10% owner
Sell indirect
17,094
$3.66
$62.62K
Aladar Szalay
14 May 2024
10% owner
Sell indirect
15,426
$3.58
$55.27K
Aladar Szalay
13 May 2024
10% owner
Sell indirect
3,446
$3.62
$12.48K
Aladar Szalay
8 May 2024
10% owner
Sell indirect
13,919
$3.82
$53.19K
Aladar Szalay
7 May 2024
10% owner
Sell indirect
6,025
$3.67
$22.11K
Aladar Szalay
1 May 2024
10% owner
Sell indirect
33,061
$3.30
$109.16K
Aladar Szalay
30 Apr 2024
10% owner
Sell indirect
20,535
$3.12
$63.98K
Aladar Szalay
29 Apr 2024
10% owner
Sell indirect
6,403
$3.25
$20.79K
Aladar Szalay
24 Apr 2024
10% owner
Sell indirect
8,064
$3.50
$28.25K
Aladar Szalay
23 Apr 2024
10% owner
Sell indirect
22,000
$3.49
$76.80K
Aladar Szalay
22 Apr 2024
10% owner
Sell indirect
14,331
$3.53
$50.60K
Aladar Szalay
17 Apr 2024
10% owner
Sell indirect
22,737
$3.71
$84.42K
Aladar Szalay
16 Apr 2024
10% owner
Sell indirect
48,683
$3.53
$171.80K
Yong Yu
15 Dec 2023
VP, Clinical Trial Operations
Sell
5,803
$14.18
$82.27K
Yong Yu
15 Dec 2023
VP, Clinical Trial Operations
Sell
26,732
$12.94
$345.91K
John Thomas
13 Dec 2023
Director
Sell
1,927
$13.93
$26.84K
John Thomas
13 Dec 2023
Director
Sell
7,073
$13.23
$93.55K
James L Tyree
13 Dec 2023
Director
Sell
3,347
$13.73
$45.96K
James L Tyree
13 Dec 2023
Director
Sell
5,653
$12.91
$73.01K
Yong Yu
7 Dec 2023
VP, Clinical Trial Operations
Sell
36,800
$11.85
$436.00K
Yong Yu
21 Nov 2023
VP, Clinical Trial Operations
Sell
18,665
$10.26
$191.56K
Yong Yu
20 Nov 2023
VP, Clinical Trial Operations
Sell
14,594
$11.26
$164.26K
Yong Yu
17 Nov 2023
VP, Clinical Trial Operations
Sell
3,541
$13.04
$46.17K
Aladar Szalay
25 Oct 2023
10% owner
Sell indirect
5,704
$19.40
$110.64K
Yong Yu
24 Oct 2023
VP, Clinical Trial Operations
Sold after exercise
5,200
$19.11
$99.35K
Aladar Szalay
23 Oct 2023
10% owner
Sell indirect
49,987
$19.97
$998.37K
John Thomas
16 Oct 2023
Director
Sell
881
$21.30
$18.77K
John Thomas
16 Oct 2023
Director
Sell
2,452
$20.50
$50.27K
Yong Yu
10 Oct 2023
VP, Clinical Trial Operations
Sold after exercise
400
$22.91
$9.16K
Yong Yu
10 Oct 2023
VP, Clinical Trial Operations
Sold after exercise
4,800
$21.94
$105.30K
Aladar Szalay
5 Oct 2023
10% owner
Sell indirect
985
$25.47
$25.09K
Aladar Szalay
5 Oct 2023
10% owner
Sell indirect
13,266
$24.89
$330.14K
Aladar Szalay
3 Oct 2023
10% owner
Sell indirect
75,690
$25.49
$1.93M
Aladar Szalay
28 Sep 2023
10% owner
Sell indirect
2,289
$24.12
$55.21K
Aladar Szalay
27 Sep 2023
10% owner
Sell indirect
11,257
$24.47
$275.46K
Yong Yu
26 Sep 2023
VP, Clinical Trial Operations
Sold after exercise
2,203
$24.46
$53.89K
Yong Yu
26 Sep 2023
VP, Clinical Trial Operations
Sold after exercise
1,114
$23.51
$26.20K
Yong Yu
26 Sep 2023
VP, Clinical Trial Operations
Sold after exercise
1,883
$22.54
$42.44K
Aladar Szalay
26 Sep 2023
10% owner
Sell indirect
9,600
$24.51
$235.30K
Aladar Szalay
26 Sep 2023
10% owner
Sell indirect
12,740
$24.03
$306.14K
Aladar Szalay
26 Sep 2023
10% owner
Sell indirect
7,465
$22.47
$167.74K
Aladar Szalay
25 Sep 2023
10% owner
Sell indirect
1,100
$27.81
$30.59K
Aladar Szalay
25 Sep 2023
10% owner
Sell indirect
1,900
$26.60
$50.54K
Aladar Szalay
25 Sep 2023
10% owner
Sell indirect
5,511
$25.75
$141.91K
Aladar Szalay
25 Sep 2023
10% owner
Sell indirect
3,947
$24.82
$97.96K
Aladar Szalay
22 Sep 2023
10% owner
Sell indirect
4,621
$27.76
$128.27K
Aladar Szalay
22 Sep 2023
10% owner
Sell indirect
4,421
$26.88
$118.85K
Aladar Szalay
21 Sep 2023
10% owner
Sell indirect
4,678
$28.82
$134.82K
Aladar Szalay
21 Sep 2023
10% owner
Sell indirect
2,871
$27.89
$80.06K
Sean Ryder
20 Sep 2023
General Counsel
Sold after exercise
10,000
$30.00
$300.00K
Yong Yu
20 Sep 2023
VP, Clinical Trial Operations
Sold after exercise
6,000
$27.96
$167.79K
Aladar Szalay
19 Sep 2023
10% owner
Sell
8,247
$27.16
$223.98K
Aladar Szalay
19 Sep 2023
10% owner
Sell
23,920
$26.21
$626.96K
John Thomas
18 Sep 2023
Director
Sell
3,334
$24.99
$83.32K
Aladar Szalay
18 Sep 2023
10% owner
Sell indirect
2,927
$24.17
$70.75K
Aladar Szalay
18 Sep 2023
10% owner
Sell indirect
27,365
$23.20
$634.90K
John Thomas
15 Sep 2023
Director
Sell
1,088
$22.38
$24.35K
John Thomas
15 Sep 2023
Director
Sell
2,245
$21.67
$48.64K
Yong Yu
15 Sep 2023
VP, Clinical Trial Operations
Sold after exercise
4,675
$22.29
$104.21K
Yong Yu
15 Sep 2023
VP, Clinical Trial Operations
Sold after exercise
5,725
$21.56
$123.42K
Aladar Szalay
14 Sep 2023
10% owner
Sell indirect
13,871
$22.31
$309.52K
Aladar Szalay
14 Sep 2023
10% owner
Sell indirect
11,405
$21.77
$248.28K
John W Smither
13 Sep 2023
Director
Sell
900
$20.78
$18.70K
Aladar Szalay
13 Sep 2023
10% owner
Sell indirect
3,315
$22.31
$73.96K
Aladar Szalay
13 Sep 2023
10% owner
Sell indirect
15,717
$21.26
$334.13K
Yong Yu
13 Sep 2023
VP, Clinical Trial Operations
Sell
29,800
$21.14
$629.93K
Aladar Szalay
12 Sep 2023
10% owner
Sell indirect
13,727
$22.51
$308.94K
Aladar Szalay
12 Sep 2023
10% owner
Sell indirect
6,538
$21.75
$142.23K
Aladar Szalay
11 Sep 2023
10% owner
Sell indirect
23,020
$22.55
$519.16K
Aladar Szalay
11 Sep 2023
10% owner
Sell indirect
9,331
$21.39
$199.55K
Aladar Szalay
8 Sep 2023
10% owner
Sell indirect
2,636
$24.19
$63.75K
Aladar Szalay
8 Sep 2023
10% owner
Sell indirect
8,523
$23.49
$200.17K
Aladar Szalay
8 Sep 2023
10% owner
Sell indirect
13,672
$22.78
$311.41K
Aladar Szalay
7 Sep 2023
10% owner
Sell indirect
2,508
$25.34
$63.55K
Aladar Szalay
7 Sep 2023
10% owner
Sell indirect
9,938
$24.12
$239.72K
Yong Yu
30 Aug 2023
VP, Clinical Trial Operations
Sell
19,800
$24.70
$489.06K
Thomas Zindrick
18 Aug 2023
President and CEO
Sell
8,349
$23.73
$198.12K
Yong Yu
18 Aug 2023
VP, Clinical Trial Operations
Sell
3,265
$23.73
$77.48K
Joseph Cappello
18 Aug 2023
VP, Pharmaceutical Development
Sell
3,265
$23.73
$77.48K
Sean Ryder
18 Aug 2023
General Counsel
Sell
328
$23.73
$7.78K
Doug Samuelson
18 Aug 2023
Chief Financial Officer
Sell
1,297
$23.73
$30.78K
Ralph Smalling
18 Aug 2023
Head of Regulatory
Sell
935
$23.73
$22.19K
Caroline Jewett
18 Aug 2023
Head of Quality
Sell
515
$23.73
$12.22K
Qian Zhang
26 Jan 2023
Associate VP, Research
Buy indirect
200
$6.25
$1.25K

What was left out

Form 4 filings counted 166
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 10
Sales at will 128
Transactions with no price 9
Shares from compensation/vesting 4,605,497
History held since 30 Jan 2023